These results suggest that the SMAD2/3 transcription factor induces lncRNA-ATB expression in GBM, and it promotes TGF-β-mediated GBM invasion through the NF-κB and p38/MAPK pathways. This evidence concerns the gene TGFB1 and glioblastoma.